Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Masitinib for the Treatment of Alzheimer’s Disease
HTML
Details
Locations
Year:
2021
Type:
review
Source:
Neurodegenerative Disease Management
DOI:
10.2217/nmt-2021-0019
Authors:
Miren Ettcheto,
Amanda Cano,
Elena Sanchez-López,
Ester Verdaguer,
Jaume Folch,
Carme Auladell,
Antoni Camins
show all 7
Institutions:
Biomedical Research Networking Center on Neurodegenerative Diseases,
Universitat de Barcelona,
Universitat Internacional de Catalunya,
Fundació ACE,
Universitat Rovira i Virgili
Language:
English
Topic:
Alzheimer's disease research and treatments
Subfield:
Cellular and Molecular Neuroscience
Field:
Neuroscience
Domain:
Life Sciences
Keywords:
masitinib,
Alzheimer's disease,
tyrosine kinase inhibitors,
mast cell inhibition,
microglial activation,
amyloid-beta,
tau protein,
synaptic damage,
cognitive function,
drug safety and tolerability
show all 10
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W3194662903
FWCI:
0.523
Cites:
86
Cited by:
30
Related to:
9